IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies

Eugenia R. Zanella, Francesco Galimi, Francesco Sassi, Giorgia Migliardi, Francesca Cottino, Simonetta M. Leto, Barbara Lupo, Jessica Erriquez, Claudio Isella, Paolo M. Comoglio, Enzo Medico, Sabine Tejpar, Eva Budinská, Livio Trusolino, Andrea Bertotti

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies'. Together they form a unique fingerprint.

Medicine & Life Sciences